Mr. Vincent joined Oncternal in April of 2017 as chief financial officer. He is an accomplished executive with over 25 years of experience in corporate finance, strategic and operational planning and execution; private and public offerings in early stage private start-ups through mature large-size international public companies across multiple industries. He has held senior management positions at Avalyn Pharma (co-founder), Zavante Therapeutics, Meritage Pharma, Sorrento Therapeutics, Elevation Pharmaceuticals, Suneva Medical, Verus Pharmaceuticals, Women First HealthCare, Elan Pharmaceuticals, Phase Metrics, and Deloitte & Touche LLP, where he specialized in emerging growth and publicly-reporting companies. His areas of responsibility have spanned all areas of finance, treasury, investor and public relations, human resources, information technology, facilities and project management.

Over the past 20 years, Mr. Vincent’s experience includes raising capital through angels, venture capital, crossover investors, major commercial banks and institutions, and public offering proceeds for high growth pharmaceutical and technology-based companies, and participating in a number of acquisitions, divestitures and license activities. Mr. Vincent was named 2014 public company CFO of the Year in San Diego by the San Diego Business Journal. He became a Certified Public Accountant in California and holds a B.S. degree in business from San Diego State University.